Itepekimab structure
|
Common Name | Itepekimab | ||
---|---|---|---|---|
CAS Number | 2226742-52-3 | Molecular Weight | N/A | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | N/A | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of ItepekimabItepekimab (REGN-3500; SAR-440340) is a monoclonal antibody of IL-33. Itepekimab reduces airway inflammation and related tissue damage in previous clinical studies. Itepekimab has clinical activity in asthma and has potential role in chronic obstructive pulmonary disease (COPD) and pediatric atopic dermatitis (AD)[1][2][3][4]. |
Name | Itepekimab |
---|
Description | Itepekimab (REGN-3500; SAR-440340) is a monoclonal antibody of IL-33. Itepekimab reduces airway inflammation and related tissue damage in previous clinical studies. Itepekimab has clinical activity in asthma and has potential role in chronic obstructive pulmonary disease (COPD) and pediatric atopic dermatitis (AD)[1][2][3][4]. |
---|---|
Related Catalog | |
In Vitro | Itepekimab 降低了戒烟者血液中嗜酸性粒细胞数[5]。 |
References |
[5]. Singh D. IL-33 in COPD: the hunt for responder subgroups. Lancet Respir Med. 2022 May;10(5):425-426. |
No Any Chemical & Physical Properties |